Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OPNT | CPIX | ACRV | ||
| Company | Opiant Pharmaceuticals Inc | Cumberland Pharmaceu | Acrivon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.88 | 7.59 | 2.33 | ||
| High | 21.00 | 7.90 | 2.37 | ||
| Low | 20.50 | 7.54 | 2.17 | ||
| Last | 20.65 | 7.80 | 2.23 | ||
| Change | -0.12 | +0.15 | -0.16 | ||
| Percent Change | -0.58% | +1.96% | -6.69% | ||
| Volume | 562,700 | 100,297 | 383,152 | ||
| 20-Day Average Volume | 83,820 | 106,020 | 416,840 | ||
| Previous | 20.77 | 7.65 | 2.39 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 20.78 | 7.43 | 1.75 | ||
| 20-Day Raw Stochastic | 44.71% | 80.98% | 87.24% | ||
| 20-Day Relative Strength | 55.75 | 59.40 | 67.00 | ||
| Weighted Alpha | -33.30 | +119.25 | +84.90 | ||
| Today's Opinion | 88% Buy | 100% Buy | 56% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 48% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.05% since 02/22/23 | -0.38% since 08/13/26 | +22.43% since 08/13/26 | ||
| Low | 20.50 on 03/01/23 | 7.54 on 08/20/26 | 1.85 on 08/14/26 | ||
| High | 21.04 on 02/24/23 | 8.07 on 08/14/26 | 2.39 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +3.10% since 02/01/23 | +7.81% since 07/20/26 | +30.17% since 07/20/26 | ||
| Low | 20.00 on 02/02/23 | 5.40 on 08/03/26 | 1.41 on 07/30/26 | ||
| High | 21.46 on 02/16/23 | 8.45 on 08/10/26 | 2.39 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +2.28% since 12/01/22 | +42.31% since 05/20/26 | +28.69% since 05/20/26 | ||
| Low | 19.96 on 01/26/23 | 5.40 on 08/03/26 | 1.36 on 06/11/26 | ||
| High | 21.46 on 02/16/23 | 8.45 on 08/10/26 | 2.39 on 08/19/26 | ||
| 6-Month | |||||
| %Chg | +83.72% since 09/01/22 | +101.79% since 02/20/26 | +48.04% since 02/20/26 | ||
| Low | 9.12 on 11/07/22 | 2.69 on 03/19/26 | 1.27 on 03/30/26 | ||
| High | 21.46 on 02/16/23 | 8.45 on 08/10/26 | 2.39 on 08/19/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 106,641 | 114,620 | 102,419 | ||
| Shares Outstanding, K | 5,164 | 14,983 | 42,853 | ||
| Annual Sales, $M | 47,790,000 | 44,520,000 | 0 | ||
| Annual Net Income, $M | 3,010,000 | -2,840,000 | -77,910,000 | ||
| Last Qtr Sales, $M | 170,000 | 170,000 | 0 | ||
| Last Qtr Income, $M | -9,920,000 | -4,270,000 | -17,960,000 | ||
| 60-Month Beta | 0.84 | 0.08 | 1.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.93 on 11/14/22 | -0.20 on 08/04/26 | -0.43 on 08/12/26 | ||
| Latest Earnings Date | 03/21/23 | 11/03/26 | 11/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | 09/10/12 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||